A Study of SHR-1501 in Patients With Advanced Tumors
NCT04025957
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Malignancies
Interventions
DRUG:
SHR-1501
Sponsor
Jiangsu HengRui Medicine Co., Ltd.